Hanbei Chen
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Thyroid Disorders and Treatments
- Natural Antidiabetic Agents Studies
Papers in
-
- Diet, Metabolism, and Disease 2
- Natural Antidiabetic Agents Studies 2
- Surgery 4
- Cholesterol and Lipid Metabolism 3
- Co-authors
- Ning Lin (4 shared papers)Qing Su (4 shared papers)Hongmei Zhang (1 shared paper)Xiaoyu Wan (1 shared paper)Minle Li (5 shared papers)Lifang Wu (5 shared papers)Yemin Zhu (5 shared papers)Xuemei Tong (5 shared papers)
- Journals
- Cell Death and Disease (1 paper)Medicine (1 paper)Aging Cell (1 paper)Diabetes (1 paper)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hanbei Chen
13 papers receiving 351 citations
Peers
Comparison fields: 5 of 64
- Clinical Biochemistry 57
- Endocrinology, Diabetes and Metabolism 93
- Applied Microbiology and Biotechnology 6
- Cancer Research 41
- Cell Biology 44
Countries citing papers authored by Hanbei Chen
This map shows the geographic impact of Hanbei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbei Chen more than expected).
Fields of papers citing papers by Hanbei Chen
This network shows the impact of papers produced by Hanbei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbei Chen. The network helps show where Hanbei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanbei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 75 | |
| 2 | 2021 | 65 | |
| 3 | 2020 | 45 | |
| 4 | 2014 | 43 | |
| 5 | 2020 | 28 | |
| 6 | 2016 | 21 | |
| 7 | 2018 | 20 | |
| 8 | 2013 | 19 | |
| 9 | 2017 | 14 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 9 | |
| 12 | 2024 | 5 | |
| 13 | 2022 | 2 | |
| 14 | 2025 | 0 |
About Hanbei Chen
Hanbei Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Clinical Biochemistry and Epidemiology, having authored 14 papers that have together received 355 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Cholesterol and Lipid Metabolism (3 papers), Plant biochemistry and biosynthesis (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Diet, Metabolism, and Disease (2 papers), Natural Antidiabetic Agents Studies (2 papers), MicroRNA in disease regulation (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Clinical Biochemistry (57 citations), Endocrinology, Diabetes and Metabolism (93 citations), Applied Microbiology and Biotechnology (6 citations), Cancer Research (41 citations) and Cell Biology (44 citations). Hanbei Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ning Lin, Qing Su, Hongmei Zhang, Xiaoyu Wan, Minle Li, Lifang Wu, Yemin Zhu, Xuemei Tong, Yakui Li and Xi Zhang. Their work appears in journals such as Cell Death and Disease, Medicine, Aging Cell, Diabetes and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.